Impella Devices for Cardiogenic Shock, High-Risk PCI, and Mechanical Circulatory Support: Scoping Review with ☸️SAIMSARA
SAIMSARA Journal · 20.05.2026 · 1 (1)
DOI: 10.62487/saimsara7f98a528 ↗Kurz gefasst
Scoping Review in der Zeitschrift SAIMSARA Journal, online erschienen am 20.05.2026. Die Arbeit nennt 194 Literaturangaben.
Abstract (Originalsprache)
To synthesize original evidence on Impella devices, focusing on clinical indications, outcomes, complications, device-management strategies, access and weaning approaches, bridge-to-therapy roles, and emerging implementation themes across adult and pediatric populations. The review uses 194 references and builds its evidence map from 432 original studies with 989377 total participants/sample observations (topic-deduplicated ΣN). This scoping review indicates that Impella functions as a versatile temporary mechanical circulatory support platform whose clinical value is highly context-dependent, shaped by shock severity, timing of initiation, device selection, and complication management. The most consistent signal supports a role for early, pre-PCI initiation in AMI-cardiogenic shock, reinforced by the DanGer Shock trial showing reduced 180-day mortality with routine Impella CP alongside increased composite adverse events. Across indications, recurrent themes of bleeding, hemolysis, vascular injury, and acquired von Willebrand syndrome highlight that hemodynamic benefit is closely counterbalanced by device-associated harm, with serious bleeding reported in up to 62% of supported patients in some cohorts. Larger Impella 5.0/5.5 platforms appear especially relevant for bridge-to-decision and bridge-to-transplant pathways, with selected cohorts reporting 90.3% 1-year post-transplant survival. Future randomized trials should clarify optimal timing, escalation thresholds, and anticoagulation strategies within phenotyped shock populations to resolve the persistent tension between circulatory support and device-related complications.
Zitieren
APA
(2026). Impella Devices for Cardiogenic Shock, High-Risk PCI, and Mechanical Circulatory Support: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal, 1(1). https://doi.org/10.62487/saimsara7f98a528
Vancouver
Impella Devices for Cardiogenic Shock, High-Risk PCI, and Mechanical Circulatory Support: Scoping Review with ☸️SAIMSARA. SAIMSARA Journal. 2026;1(1). doi:10.62487/saimsara7f98a528
BibTeX
@article{euvimed2026,
title = {Impella Devices for Cardiogenic Shock, High-Risk PCI, and Mechanical Circulatory Support: Scoping Review with ☸️SAIMSARA},
journal = {SAIMSARA Journal},
year = {2026},
volume = {1},
number = {1},
doi = {10.62487/saimsara7f98a528}
}
EUVIMED